Rule 24.174.524 - COLLABORATIVE PRACTICE AGREEMENT REQUIREMENTS(1) A pharmacist engaged in collaborative practice must: (a) maintain an executed written copy of the collaborative practice agreement at the pharmacy and any other location in which the practice is occurring; and (b) make the agreement available for inspection by the board.(2) The collaborative practice agreement must include:(a) identification of the practitioner(s) and pharmacist(s) who are parties to the agreement; (i) the practitioner as defined in 37-2-101, MCA, must be licensed in good standing in Montana; (b) the types of decisions that the pharmacist is allowed to make ;(c) a method for the practitioner to monitor compliance with the agreement and clinical outcomes and to intercede where necessary;(d) a provision that allows the practitioner to override a collaborative practice decision made by the pharmacist whenever the practitioner deems it necessary or appropriate;(e) a provision that allows either party to cancel the agreement by written notification;(g) signatures of collaborating pharmacists and practitioners, or a representative from the medical practice or clinic that is authorized to represent its practitioners, who are party to the agreement, as well as dates of signing; and(h) a procedure for periodic review and renewal within a time frame that is clinically appropriate.(3) Documentation of allowed pharmacist activities must be kept as part of the patient's permanent record and be readily available to other health care professionals providing care to the patient and who are authorized to receive it. Documentation of allowed activities shall be considered protected health information.(4) Collaborative practice agreements approved by an institutional committee such as the pharmacy and therapeutics committee and that will be used solely for patients while they are receiving care in the institution are exempt.Mont. Admin. r. 24.174.524
NEW, 2002 MAR p. 794, Eff. 2/1/02; AMD, 2006 MAR p. 1615, Eff. 6/23/06; AMD, 2007 MAR p. 1936, Eff. 11/22/07; AMD, 2019 MAR p. 1633, Eff.9/21/2019; AMD, 2021 MAR p. 1671, Eff. 11/20/2021AUTH: 37-7-201, MCA IMP: 37-7-101, 37-7-201, MCA